Amyotrophic Lateral Sclerosis Clinical Trials

• Familial Amyotrophic Lateral Sclerosis. A Preliminary Study to Identify Subjects Who Might Be Willing to Participate in a Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00136500 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Safety Study of Oral Sodium Phenylbutyrate in Subjects with ALS (Amyotrophic Lateral Sclerosis)
  ClinicalTrials.gov Identifier: NCT00107770 - Active, not recruiting
  Amyotrophic Lateral Sclerosis
  
• R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00140218 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Determinants of Disease Severity in Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00004457 - Active, not recruiting
  Amyotrophic Lateral Sclerosis
  
• Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00339976 - Active, not recruiting
  Amyotrophic Lateral Sclerosis; ALS
  
• Early Treatment of Amyotrophic Lateral Sclerosis (ALS) with Nutrition and Non-Invasive Positive Pressure Ventilation (NIPPV)
  ClinicalTrials.gov Identifier: NCT00116558 - Active, not recruiting
  Amyotrophic Lateral Sclerosis
  
• Study of Creatine Monohydrate in Patients with Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00069186 - Active, not recruiting
  Amyotrophic Lateral Sclerosis (ALS)
  
• A 12-week, multicenter, safety and dose-ranging study of 3 oral doses of TCH346 in patients with Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00036413 - Completed
  Amyotrophic Lateral Sclerosis
  
• Effect of Noninvasive Ventilation on Lung Function in Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00537446 - Recruiting
  Amyotrophic Lateral Sclerosis; Motor Neuron Disease
  
• Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org
  ClinicalTrials.gov Identifier: NCT00302198 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Confirmation of Self-Reported Amyotrophic Lateral Sclerosis Cases in the AARP-Diet and Health Study
  ClinicalTrials.gov Identifier: NCT00377351 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Study Evaluating TCH346 and Placebo Administered Once Daily in Patients with Amyotrophic Lateral Sclerosis (ALS)
  ClinicalTrials.gov Identifier: NCT00072709 - Completed
  Amyotrophic Lateral Sclerosis
  
• Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00005766 - Completed
  Amyotrophic Lateral Sclerosis
  
• Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)
  ClinicalTrials.gov Identifier: NCT00326625 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Molecular Imaging Modality by Positron Emission Tomography Using 18F-X : Study of Microglial Activation in Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00563537 - Recruiting
  Amyotrophic Lateral Sclerosis; Bulbar Disease; Spinal Disease
  
• Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III
  ClinicalTrials.gov Identifier: NCT00415519 - Recruiting
  Amyotrophic Lateral Sclerosis (ALS)
  
• Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)
  ClinicalTrials.gov Identifier: NCT00424463 - Recruiting
  Amyotrophic Lateral Sclerosis (ALS)
  
• Genetic Epidemiology of Familial Amyotrophic Lateral Sclerosis (ALS)
  ClinicalTrials.gov Identifier: NCT00317616 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Safety and Efficacy Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients with ALS
  ClinicalTrials.gov Identifier: NCT00125203 - Active, not recruiting
  Amyotrophic Lateral Sclerosis; Sialorrhea
  
• Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)
  ClinicalTrials.gov Identifier: NCT00403104 - Recruiting
  Amyotrophic Lateral Sclerosis (ALS)
  
• A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00213824 - Recruiting
  Amyotropic Lateral Sclerosis
  
• Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)
  ClinicalTrials.gov Identifier: NCT00420719 - Recruiting
  Amyotrophic Lateral Sclerosis (ALS)
  
• The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrofic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00160004 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)
  ClinicalTrials.gov Identifier: NCT00353665 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Is there a higher than expected occurrence of Amyotrophic Lateral Sclerosis (ALS) among deployed veterans as compared to non-deployed Gulf War veterans?
  ClinicalTrials.gov Identifier: NCT00007722 - Completed
  Amyotrophic Lateral Sclerosis
  
• Clinical trial of creatine in amyotrophic lateral sclerosis [ALS]
  ClinicalTrials.gov Identifier: NCT00005674 - Completed
  Amyotrophic Lateral Sclerosis
  
• Creatine for the Treatment of Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00070993 - Completed
  Amyotrophic Lateral Sclerosis
  
• Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00334516 - Recruiting
  Cerebral Cortex Dysfunction
  
• A Long-Term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)
  ClinicalTrials.gov Identifier: NCT00230074 - Completed
  Amyotrophic Lateral Sclerosis
  
• Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00023075 - Completed
  Primary Lateral Sclerosis; Hereditary Spastic Paraplegia; Amyotrophic Lateral Sclerosis
  
• G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response
  ClinicalTrials.gov Identifier: NCT00397423 - Completed
  Amyotrophic Lateral Sclerosis
  
• A Randomised Sequential Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00136110 - Completed
  Amyotrophic Lateral Sclerosis (ALS)
  
• Minocycline to Treat Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00047723 - Completed
  Amyotrophic Lateral Sclerosis
  
• Exogenous Toxicants and Genetic Susceptibility in ALS
  ClinicalTrials.gov Identifier: NCT00011154 - Completed
  Amyotrophic Lateral Sclerosis
  
• Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00355576 - Completed
  Amyotrophic Lateral Sclerosis
  
• IGF-1/ALS Trial
  ClinicalTrials.gov Identifier: NCT00035815 - Completed
  Amyotrophic Lateral Sclerosis
  
• Frontotemporal Dementia and Amytrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00140777 - Recruiting
  Frontotemporal dementia; and/or; Lateral amyotrophic sclerosis
  
• Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease
  ClinicalTrials.gov Identifier: NCT00324454 - Active, not recruiting
  Motor Neuron Disease; Amyotrophic Lateral Sclerosis; Primary Lateral Sclerosis; Progressive Muscular Atrophy
  
• Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS
  ClinicalTrials.gov Identifier: NCT00021697 - Completed
  Amyotrophic Lateral Sclerosis
  
• Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)
  ClinicalTrials.gov Identifier: NCT00231140 - Terminated
  Amyotrophic Lateral Sclerosis (ALS)
  
• Effects of Gastrostomy on Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00337402 - Completed
  Amyotrophic Lateral Sclerosis
  
• Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]
  ClinicalTrials.gov Identifier: NCT00214110 - Completed
  Amyotrophic Lateral Sclerosis (ALS)
  
• Clinical Trial of High Dose CoQ10 in ALS
  ClinicalTrials.gov Identifier: NCT00243932 - Active, not recruiting
  Amyotrophic Lateral Sclerosis; Lou Gehrig's Disease
  
• Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying)
  ClinicalTrials.gov Identifier: NCT00056524 - Completed
  Amyotrophic Lateral Sclerosis; Multiple Sclerosis; Alzheimer's Disease; Stroke; Traumatic Brain Injury
  
• Mitochondrial Functions and Oxidative Stress in ALS Patients
  ClinicalTrials.gov Identifier: NCT00331812 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Efficacy of Noninvasive Ventilation in ALS
  ClinicalTrials.gov Identifier: NCT00537641 - Recruiting
  Amyotrophic Lateral Sclerosis; Motor Neuron Disease
  
• Clinical Trial of Vitamin E to Treat Muscular Cramps in Patients With ALS
  ClinicalTrials.gov Identifier: NCT00372879 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in ALS
  ClinicalTrials.gov Identifier: NCT00409721 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Influence of G-CSF and EPO on Associative Learning and Motor Skills
  ClinicalTrials.gov Identifier: NCT00298597 - Recruiting
  Chronic Stroke; Amyotrophic Lateral Sclerosis
  
• Clinical Trial Ceftriaxone in Subjects With ALS
  ClinicalTrials.gov Identifier: NCT00349622 - Recruiting
  Amyotrophic Lateral Sclerosis; ALS
  
• A Long-Term Study in Patients With ALS
  ClinicalTrials.gov Identifier: NCT00445172 - Recruiting
  Amyotrophic Lateral Sclerosis (ALS)
  
• A Phase II/III Study in Patients With ALS
  ClinicalTrials.gov Identifier: NCT00444613 - Recruiting
  Amyotrophic Lateral Sclerosis (ALS)
  
• Pilot Placebo-Controlled Trial of Early Noninvasive Ventilation for ALS
  ClinicalTrials.gov Identifier: NCT00580593 - Recruiting
  Amyotrophic Lateral Sclerosis; ALS
  
• A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS
  ClinicalTrials.gov Identifier: NCT00561366 - Not yet recruiting
  Amyotrophic Lateral Sclerosis
  
• Phase II Study Using Thalidomide for the Treatment of ALS
  ClinicalTrials.gov Identifier: NCT00140452 - Completed
  Amyotrophic Lateral Sclerosis; ALS
  
• Derivation of Primary Donor Cell Lines for Human Somatic Cell Nuclear Transfer
  ClinicalTrials.gov Identifier: NCT00553826 - Recruiting
  Parkinson Disease; Amyotrophic Lateral Sclerosis; Diabetes, Type I
  
• Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
  ClinicalTrials.gov Identifier: NCT00159198 - Terminated
  Frontotemporal dementia; Lateral amyotrophic sclerosis
  
• CARE Canadian ALS Riluzole Evaluation
  ClinicalTrials.gov Identifier: NCT00542412 - Completed
  Amyotrophic Lateral Sclerosis
  
• Study of the Effects Strengthening Exercises in Individuals With ALS
  ClinicalTrials.gov Identifier: NCT00204464 - Completed
  Amyotrophic Lateral Sclerosis
  
• Phase II Study of Leuprolide and Testosterone for Men with Kennedy's Disease or Other Motor Neuron Disease
  ClinicalTrials.gov Identifier: NCT00004771 - Completed
  Spinal Muscular Atrophy; Amyotrophic Lateral Sclerosis; Spinobulbar Muscular Atrophy
  
• Noninvasive Ventilation in ALS Patients With Mild Respiratory Involvement
  ClinicalTrials.gov Identifier: NCT00386464 - Completed
  Amyotrophic Lateral Sclerosis
  
• A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS
  ClinicalTrials.gov Identifier: NCT00244244 - Completed
  Amyotrophic Lateral Sclerosis (ALS)
  
• Non-Invasive Ventilation in ALS
  ClinicalTrials.gov Identifier: NCT00560287 - Not yet recruiting
  Amiotrophyc Lateral Sclerosis; Chrinic Respiratory Failure
  
• Isolated Mild Fetal Ventriculomegaly and Neurodevelopmental Outcome
  ClinicalTrials.gov Identifier: NCT00256906 - Recruiting
  Lateral Ventricles
  
• BEYOND Study - Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
  ClinicalTrials.gov Identifier: NCT00099502 - Active, not recruiting
  Multiple Sclerosis
  
• Safety of RG2077 in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00076934 - Active, not recruiting
  Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
  
• Rebif® New Formulation in Relapsing Forms of Multiple Sclerosis (RMS)
  ClinicalTrials.gov Identifier: NCT00110396 - Active, not recruiting
  Multiple Sclerosis
  
• Combination Therapy with Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00037102 - Active, not recruiting
  Multiple Sclerosis
  
• A Study to Evaluate Rituximab in Adults with Relapsing Remitting Multiple Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00097188 - Active, not recruiting
  Multiple Sclerosis
  
• A Study to Evaluate the Safety and Efficacy of Rituximab in Adults with Primary Progressive Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00087529 - Active, not recruiting
  Multiple Sclerosis
  
• Auditory Function in Patients With and Without Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00037947 - Recruiting
  Multiple Sclerosis
  
• Efficacy Study of Prolotherapy Vs Corticosteroid for Tennis Elbow
  ClinicalTrials.gov Identifier: NCT00160303 - Recruiting
  Lateral epicondylitis
  
• Immunotherapy with BHT-3009 Alone or Combined with Atorvastatin in Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00103974 - Active, not recruiting
  Multiple Sclerosis
  
• Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00411723 - Recruiting
  Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting
  
• Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients with Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00006393 - Recruiting
  Systemic Sclerosis
  
• EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00137176 - Recruiting
  Multiple Sclerosis
  
• EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00146068 - Recruiting
  Multiple Sclerosis
  
• Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
  ClinicalTrials.gov Identifier: NCT00220493 - Recruiting
  Relapsing Remitting Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive
  
• Lateral Epicondylitis Iontophoresis Randomized Control Trial (LERCT)
  ClinicalTrials.gov Identifier: NCT00435318 - Not yet recruiting
  Lateral Epicondylitis
  
• Improving Memory in Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00062972 - Recruiting
  Multiple Sclerosis
  
• Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
  ClinicalTrials.gov Identifier: NCT00001248 - Recruiting
  Multiple Sclerosis
  
• Magnetic Resonance Imaging to Detect Brain Damage in Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00099307 - Recruiting
  Multiple Sclerosis
  
• Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis With Optional Extension Phase
  ClinicalTrials.gov Identifier: NCT00340834 - Active, not recruiting
  Multiple Sclerosis
  
• Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00246324 - Active, not recruiting
  Multiple Sclerosis
  
• GER-009-06-AVX Early Therapy in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00492570 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Extension Study to Evaluate Safety, Tolerability and Effects on Efficacy Parameters of FTY720 in Patients With Relapsing Multiple Sclerosis.
  ClinicalTrials.gov Identifier: NCT00235430 - Active, not recruiting
  Multiple Sclerosis
  
• Prospective, Open-Label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients
  ClinicalTrials.gov Identifier: NCT00262314 - Active, not recruiting
  Multiple Sclerosis
  
• Zenapax to Treat Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00001934 - Active, not recruiting
  Multiple Sclerosis
  
• Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00289978 - Active, not recruiting
  Multiple Sclerosis
  
• Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00342134 - Active, not recruiting
  Multiple Sclerosis
  
• Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00381264 - Active, not recruiting
  Multiple Sclerosis
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00004744 - Active, not recruiting
  Multiple Sclerosis
  
• Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00179478 - Active, not recruiting
  Multiple Sclerosis; Optic Neuritis; Transverse Myelitis; Acute Brainstem/Cerebellar Syndrome
  
• POPART''MUS : Prevention of Post Partum Relapses with Progestin and Estradiol in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00127075 - Recruiting
  Multiple Sclerosis
  
• Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up
  ClinicalTrials.gov Identifier: NCT00289159 - Active, not recruiting
  Multiple Sclerosis
  
• Atorvastatin Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00094172 - Recruiting
  Multiple Sclerosis
  
• Treatment of Multiple Sclerosis with Copaxone and Albuterol
  ClinicalTrials.gov Identifier: NCT00039988 - Active, not recruiting
  Autoimmune Diseases; Multiple Sclerosis
  
• Combination Therapy of Betaseron-Prograf in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00298662 - Active, not recruiting
  Multiple Sclerosis
  
• Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
  ClinicalTrials.gov Identifier: NCT00004645 - Active, not recruiting
  Acute Disseminated Encephalomyelitis; Devic's Syndrome; Marburg's variant of multiple sclerosis; Balo's Concentric Sclerosis; ...
  
• Follow-up Study of the BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment)
  ClinicalTrials.gov Identifier: NCT00185211 - Active, not recruiting
  Multiple Sclerosis